Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT05021991

Public ClinicalTrials.gov record NCT05021991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 8:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of PRAX-944 in the Treatment of Adults With Essential Tremor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multi-center, randomized, double-blinded, placebo-controlled, dose-range-finding clinical trial (with an optional Extension comprised of an Extension Double-blind (DB) Lead in Period followed by an Extension Open-label (OL) Period) that will assess the efficacy, safety, and tolerability of PRAX 944 in participants aged 18 years or older who have a diagnosis of Essential Tremor (ET) and have had symptoms for at least 3 years.

Study identification

NCT ID
NCT05021991
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Praxis Precision Medicines
Industry
Enrollment
133 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 13, 2021
Primary completion
Feb 8, 2023
Completion
Feb 28, 2024
Last update posted
Mar 12, 2024

2021 – 2024

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Praxis Research Site Birmingham Alabama 35294
Praxis Research Site Little Rock Arkansas 72205
Praxis Research Site San Diego California 92103
Praxis Research Site Santa Monica California 90404
Praxis Research Site Torrance California 90503
Praxis Research Site Aurora Colorado 80045
Praxis Research Site Boca Raton Florida 33486
Praxis Research Site Gainesville Florida 32608
Praxis Research Site Jacksonville Florida 32209
Praxis Research Site Port Charlotte Florida 33980
Praxis Research Site St. Petersburg Florida 33713
Praxis Research Site Tampa Florida 33612
Praxis Research Site West Palm Beach Florida 33407
Praxis Research Site Chicago Illinois 60612
Praxis Research Site Kansas City Kansas 66160
Praxis Research Site Louisville Kentucky 40202
Praxis Research Site Rockville Maryland 20852
Praxis Research Site Boston Massachusetts 02118
Praxis Research Site Burlington Massachusetts 01805
Praxis Research Site Farmington Hills Michigan 48334
Praxis Research Site Golden Valley Minnesota 55427
Praxis Research Site Las Vegas Nevada 89106
Praxis Research Site New York New York 10029
Praxis Research Site New York New York 10032
Praxis Research Site Cincinnati Ohio 45212
Praxis Research Site Philadelphia Pennsylvania 19107
Praxis Research Site Georgetown Texas 78628
Praxis Research Site Houston Texas 77030
Praxis Research Site Round Rock Texas 78681
Praxis Research Site Burlington Vermont 05401
Praxis Research Site Alexandria Virginia 22311
Praxis Research Site Virginia Beach Virginia 23456
Praxis Research Site Kirkland Washington 98034
Praxis Research Site Spokane Washington 99202
Praxis Research Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05021991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2024 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05021991 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →